Biomarker discovery and metabolic profiling in serum of cardiovascular disease patients with untargeted metabolomics and machine learning

Xia Shen , Shuyuan Guo , Ningning Liang , Mingming Zhao , Chun Wang , Zi Li , Dewen Yan , Lemin Zheng , Huiyong Yin

Clinical and Translational Medicine ›› 2024, Vol. 14 ›› Issue (6) : e1722

PDF
Clinical and Translational Medicine ›› 2024, Vol. 14 ›› Issue (6) : e1722 DOI: 10.1002/ctm2.1722
LETTER TO THE JOURNAL

Biomarker discovery and metabolic profiling in serum of cardiovascular disease patients with untargeted metabolomics and machine learning

Author information +
History +
PDF

Cite this article

Download citation ▾
Xia Shen, Shuyuan Guo, Ningning Liang, Mingming Zhao, Chun Wang, Zi Li, Dewen Yan, Lemin Zheng, Huiyong Yin. Biomarker discovery and metabolic profiling in serum of cardiovascular disease patients with untargeted metabolomics and machine learning. Clinical and Translational Medicine, 2024, 14(6): e1722 DOI:10.1002/ctm2.1722

登录浏览全文

4963

注册一个新账户 忘记密码

References

[1]

Karjalainen MK, Karthikeyan S, Oliver-Williams C, et al. Genome-wide characterization of circulating metabolic biomarkers. Nature. 2024;628(8006):130-138.

[2]

Lu J, Chen B, Chen T, et al. Comprehensive metabolomics identified lipid peroxidation as a prominent feature in human plasma of patients with coronary heart diseases. Redox Biol. 2017;12:899-907.

[3]

Cavus E, Karakas M, Ojeda FM, et al. Association of circulating metabolites with risk of coronary heart disease in a European Population: results from the Biomarkers for Cardiovascular Risk Assessment in Europe (BiomarCaRE) Consortium. JAMA Cardiol. 2019;4(12):1270-1279.

[4]

Wittenbecher C, Eichelmann F, Toledo E, et al. Lipid profiles and heart failure risk: results from two prospective studies. Circ Res. 2021;128(3):309-320.

[5]

Shen X, Liang N, Liu Z, et al. Serum metabolomics identifies dysregulated pathways and potential metabolic biomarkers for hyperuricemia and gout. Arthritis Rheumatol. 2021;73(9):1738-1748.

[6]

Shao F, Li R, Guo Q, et al. Plasma metabolomics reveals systemic metabolic alterations of subclinical and clinical hypothyroidism. J Clin Endocrinol Metab. 2022;108(1):13-25.

[7]

Triba MN, Le Moyec L, et al. PLS/OPLS models in metabolomics: the impact of permutation of dataset rows on the K-fold cross-validation quality parameters. Mol Biosyst. 2015;11(1):13-19.

[8]

Tibshirani R. The lasso method for variable selection in the Cox model. Stat Med. 1997;16(4):385-395.

[9]

Sumner LW, Amberg A, Barrett D, et al. Proposed minimum reporting standards for chemical analysis Chemical Analysis Working Group (CAWG) Metabolomics Standards Initiative (MSI). Metabolomics. 2007;3(3):211-221.

[10]

Nettleman MD. Receiver operator characteristic (ROC) curves. Infect Control Hosp Epidemiol. 1988;9(8):374-377.

RIGHTS & PERMISSIONS

2024 The Author(s). Clinical and Translational Medicine published by John Wiley & Sons Australia, Ltd on behalf of Shanghai Institute of Clinical Bioinformatics.

AI Summary AI Mindmap
PDF

193

Accesses

0

Citation

Detail

Sections
Recommended

AI思维导图

/